Haematology
- DISEASE INDICATIONS: Thromboembolism
- MANUFACTURER: Alexion Pharmaceuticals
- USAGE: Intravenous
- MEDICINE APPROVED BY:
- European Medical Agency (EMA)
- Food and Drug Administration (FDA)
Andexxa, with the generic name coagulation factor Xa (recombinant), inactivated-zhzo, is a specialized medication used for the reversal of anticoagulation effects caused by certain direct oral anticoagulants (DOACs) that target factor Xa. This medication is designed to rapidly reverse the anticoagulant effects of DOACs, which are commonly used to prevent or treat blood clots but can pose a risk of excessive bleeding in certain situations.
$24,706.00
Select optionsThis product has multiple variants. The options may be chosen on the product page
